Previous 10 | Next 10 |
home / stock / vphif / vphif news
The health crisis has completely changed life as we know it and caused a significant shift in consumer demand for immune-boosting products, vitamins, and supplements. Now, due to growing awareness around heath, the wellness supplements market is projected to reach $386.29 bill...
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – January 25, 2021 – The health crisis has completely changed life as we know it and caused a significant shift in consumer demand for immune-boosting products, vitamins, and supplements. ...
Valeo Pharma's Redesca™ Receives Positive Recommendation for Public Reimbursement in Quebec Canada NewsWire MONTREAL , Jan. 25, 2021 /CNW Telbec/ - Valeo Pharma Inc . (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadi...
Valeo Pharma Announces Major Addition to its Senior Management Team Canada NewsWire Frederic Fasano named President and COO Steve Saviuk continues as CEO and becomes Vice-Chairman of the Board of Directors MONTREAL , Jan. 18, 2021 /CNW...
Valeo Pharma Highlights MDBriefCase Newsletter Comparing Hesperidin and Vitamin C for COVID-19 Canada NewsWire Growing body of research suggests Hesperidin may interfere with SARS-CoV-2 infection process Hesperidin may help against Covid-19 viral replication ...
Valeo Pharma Announces DTC Eligibility for the Trading of Its Shares on the US OTCQB Market Canada NewsWire MONTREAL , Dec. 29, 2020 /CNW Telbec/ - Valeo Pharma Inc . ( CSE: VPH) (OTCQB: VPHIF) (FSE: VP2 ) (" Valeo "), a Canadian pharmaceutica...
Valeo Pharma Announces Health Canada Approval for Redesca™ and Redesca Hp™ Commercial launch to impact first half 2021 revenue $30 million forecasted annual peak sales 8 years of proven in-market safety Internationally Low molecular ...
Valeo Pharma announces Amikacin approval in CANADA and U.S. launch of Ethacrynate Sodium Canada NewsWire MONTREAL, Nov. 12, 2020 Amikacin receives Health Canada approval, commercialization to start in first half of 2021 Strong start for Ethacrynate Sodium...
Valeo Pharma Announces That Hesperco™ Has Started Shipping PR Newswire MONTREAL, Oct. 13, 2020 Hesperco TM capsules online orders now shipping Hesperco TM capsules retailer sales to begin early November MONTREAL , Oct. 13,...
Valeo Pharma (VPHIF): FQ3 net loss of $1.6MRevenue of $1.5M (-42.3% Y/Y)Press Release For further details see: Valeo Pharma reports FQ3 results
News, Short Squeeze, Breakout and More Instantly...
VALEO PHARMA ANNOUNCES SENIOR EXECUTIVE APPOINTMENT AND BOARD OF DIRECTORS CHANGE Canada NewsWire MONTREAL , June 18, 2024 /CNW/ - Valeo Pharma Inc . (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical compan...
(NewsDirect) Valeo Pharma CEO Steve Saviuk joined Steve Darling from Proactive to discuss the company's financial results for the second quarter, which saw record-breaking revenue for the period. The company reported revenues of $14.1 million for Q2, an increase from the $13.6 million rec...
VALEO PHARMA ANNOUNCES RESTRUCTURING OF COMMERCIAL FIELD OPERATIONS TO SUPPORT PATH TO PROFITABILITY Canada NewsWire Changes to respiratory business unit to generate more than $5 million in annual savings Follows previously announced cost saving measures exce...